Clinical Trials Logo

Filter by:
NCT ID: NCT01304420 Completed - Clinical trials for Systemic Juvenile Idiopathic Arthritis

Ultrasonography in Juvenile Idiopathic Arthritis

Start date: October 2009
Phase: Phase 0
Study type: Observational

The purpose of this study is to analyse the usability of ultrasonography together with biomarkers in the investigation of patients diagnosed with juvenile idiopathic arthritis. The investigators hypothesize that serum and urine markers of cartilage and bone synthesis and degradation, together with ultrasound measurements of joint cartilage thickness, are useful tools in the early evaluation of JIA patients, - as diagnostic, prognostic and monitoring methods.

NCT ID: NCT01303978 Completed - Clinical trials for Chemotherapy-induced Nausea and Vomiting

Phase II Proof-of-concept Study of APD421

Start date: February 2011
Phase: Phase 2
Study type: Interventional

Evaluation of efficacy of APD421 in preventing nausea and vomiting caused by cisplatin

NCT ID: NCT01303224 Completed - Clinical trials for Irritable Bowel Syndrome With Diarrhea

Ibodutant for Relief of Irritable Bowel Syndrome With Diarrhoea (IBS-D)

IRIS-2
Start date: October 2010
Phase: Phase 2
Study type: Interventional

Irritable Bowel Syndrome with diarrhoea (IBS-D) is a functional gastrointestinal disorder characterised by chronic or recurrent abdominal pain or discomfort and diarrhoea. This trial aims at the evaluation of the efficacy and safety of the neurokinin type 2 receptor antagonist Ibodutant in improving IBS-D symptoms.

NCT ID: NCT01302275 Completed - Clinical trials for Postherpetic Neuralgia

Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain

IMIOXC
Start date: February 2011
Phase: Phase 4
Study type: Interventional

The purpose of this trial is to determine if the effect of oxcarbazepine on chronic peripheral nerve pain depends on the supposed mechanism of the pain, ie. if oxcarbazepine mainly relieve pain in patients with irritable nerves.

NCT ID: NCT01302067 Completed - Overactive Bladder Clinical Trials

A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine

Start date: May 2011
Phase: Phase 4
Study type: Interventional

This study is designed to confirm if 8mg of fesoterodine is more effective in reducing overactive bladder symptoms than 4mg of fesoterodine. In addition the study is designed to assess if the higher dose reduces the overall effect of overactive bladder on the subject's daily life more than the lower dose. The study also assesses the side effects and safety of the two doses.

NCT ID: NCT01302041 Completed - Prostate Cancer Clinical Trials

A Study to Test if Enzalutamide is Effective and Safe in Prostate Cancer Patients Who Have Never Had Hormone Therapy

Start date: May 6, 2011
Phase: Phase 2
Study type: Interventional

To evaluate the effect of enzalutamide on prostate specific antigen (PSA) level in men with prostate cancer.

NCT ID: NCT01300104 Completed - Prostate Cancer Clinical Trials

Feasibility Study on a Nordic Lifestyle Intervention Trial Among Men With Prostate Cancer

Start date: February 2011
Phase: N/A
Study type: Interventional

PURPOSE: To evaluate the feasibility of a future Nordic intervention trial, including vigorous activity and a high intake of whole grain rye, among prostate cancer patients on active surveillance. Additionally, to investigate effects of the lifestyle intervention according to cancer progression, the metabolic profile, inflammation and quality of life among prostate cancer patients on active surveillance.

NCT ID: NCT01299831 Completed - Healthy Clinical Trials

The Relationship Between Body Composition and Growth Hormone, SIRT Signaling, Protein Turnover and Insulin Sensitivity

Start date: January 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate signaling pathways in fat and muscle, as well as turnover of protein, sugar and fat after stimulation with growth hormone and during fasting in lean and obese subjects. This will help clarify differences in the human metabolism between lean and obese subject and provide us with a better understanding of the molecular mechanisms regulating the basic metabolism during prolonged fasting.

NCT ID: NCT01299480 Completed - Clinical trials for Meningococcal Vaccine

A Trial To Assess The Safety, Tolerability, And Immunogenicity Of Rlp2086 Vaccine When Administered In Either 2- Or 3-Dose Regimens In Healthy Subjects Aged ≥11 To <19 Years

Start date: March 3, 2011
Phase: Phase 2
Study type: Interventional

This study is to look at a new vaccine that might prevent meningococcal disease, and to look at the safety of the new vaccine as well as how well it is tolerated. This study will also look at this vaccine being given 2 or 3 times. This study will be done in healthy adolescents.

NCT ID: NCT01297725 Completed - Cesarean Section Clinical Trials

Sharp Versus Blunt Fascial Incision at Caesarean Section

Start date: January 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to compare sharp and blunt fascial entry during caesarean section on the same patient. The study is performed on woman having cesarean section for the first time and who have not previously had lower abdominal surgery done. The following parameters are registered: 1. The preferred side evaluated by the patient 3 months postoperatively. 2. The patient evaluated difference in pain on the right vs. left side 1, 3 and 7 days and 1 and 3 months postoperatively. 3. The rate and side of infection.